Radiotoxicity of systemically administered [211At]astatide in B6C3F1 and BALB/c (nu/nu) mice: A long-term survival study with histologic analysis

International Journal of Radiation Oncology Biology Physics

Volumn 35, Issue 1, 1996, Pages 69-80

  McLendon, Roger E ^a   Archer, Gerald E ^a   Garg, Pradeep K ^a   Bigner, Darell D ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B6C3F1; BALB c; Endoradiotherapy; Mice; Pathology; Survival; Systemic administration; 211At Astatide

Indexed keywords

ASTATINE 211; SODIUM CHLORIDE; ASTATINE;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BONE MARROW DEPRESSION; CONTROLLED STUDY; DOSE RESPONSE; FORESTOMACH; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LD 50; LETHALITY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIATION EXPOSURE; SURVIVAL; TESTIS ATROPHY; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW; HEART; PATHOLOGY; STOMACH; TESTIS; WEIGHT GAIN;

ANIMALS; ASTATINE; BONE MARROW; HEART; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; STOMACH; TESTIS; WEIGHT GAIN;

EID: 0029665434     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)85013-9     Document Type: Article

References (34)

1. 90Y. Int. J. Radiat. Oncol. Biol. Phys. 10:341-348; 1984.
2. Brasel, J. A.; Winick, M. Differential cellular growth in the organs of hypothyroid rats. Growth 34:197-207; 1970.
3. Brown, I. Astatine radiopharmaceuticals. Astatine-211: Its possible applications in cancer therapy. Appl. Radiat. Isotherm. 37:789-798; 1986.
4. 211At in mice with a transplanted rectal adenocarcinoma. Int. J. Appl. Radiat. Isotherm. 35:843-847; 1984.
5. 211At]-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice and associated studies. Int. J. Radiat. Oncol. Biol. Phys. 29(1):115-124; 1994.
6. Casarett, G. W. Radiation histopathology, vols. 1 & 2. Boca Raton, FL: CRC Press, Inc.; 1980.
7. Cobb, L. M.; Butler, S. A.; Harrison, A. The effect of the α-particle emitter astatine-211 in the mouse at the minimum toxic dose. Hum. Exp. Toxicol. 9:289-293; 1990.
8. Cobb, L. M.; Harrison, A.; Butler, S. A. Toxicity of astatine-211 in the mouse. Hum. Toxicol. 7:529-534; 1988.
9. Duncan, C. H.; Best, M. M.; Lubbe, R. J. Effects of L-and D-thyroxin and of thyroidectomy on tissue weights and cholesterol content of the rat. Metabolism 13(1):1-7; 1964.
10. Durbin, P. W.; Asling, C. W.; Johnston, M. E.; Parrott, M. W.; Jeung, N.; Williams, M. H.; Hamilton, J. G. The induction of tumors in the rat by astatine-211. Radiat. Res. 9:378-397; 1958.
11. 2 fragment. Cancer Res. 50:3514-3520; 1990.
12. Goldberg, R. C.; Chaikoff, I. L.; Lindsay, S.; Feller, D. D. Histopathological changes induced in the normal thyroid and other tissues of the rat by internal radiation with various doses of radioactive iodine. Endocrinology 46:72-90; 1950.
13. Goodman, D. G.; Boorman G. A.; Strandberg, J. D. Selection and use of the B6C3F1 mouse and F344 rat in long-term bioassays for carcinogenicity. In: Milman, H. A.; Weisburg, E. K., eds. Handbook of carcinogen testing. Park Ridge, NJ: Noyes Publications; 1985:282-325.
14. Hall, E. J. Radiobiology for the radiologist. 3rd ed. Philadelphia, PA: Lippincott Co; 1988:161-177.
15. Hamilton, J. G.; Asling, C. W.; Garrison, W. M.; Scott, K. G. The accumulation, metabolism and biological effects of astatine in rats and monkeys. Univ. of Calif. Pub. Pharmacol. 2(21):283-344; 1953.
16. Hamilton, J. G.; Durbin, P. W.; Asling, C. W.; Johnston, M. E. Physiological and biochemical studies of astatine-211 (eka-iodine). In: Proceedings of the international conferences on the peaceful uses of atomic energy. New York: United Nations; 1956:175-181.
17. 211 (eka-iodine) in the thyroid gland of rats and monkeys. J. Clin. Endocrinol. Metabol. 14:1161-1178; 1954.
18. 211At treated mice. Health Phys. 46:377-338; 1984.
19. Huneke, R. B.; Pippin, C. G.; Squire, R. A.; Brechbiel, M. W.; Gansow, O. A.; Strand, M. Effective α-particle-mediated radioimmunotherapy of murine leukemia. Cancer Res. 52:5818-5820; 1992.
20. Kozak, R. W.; Atcher, R. W.; Gansow, O. A., Friedman, A. M.; Hines, J. J.; Waldmann, T. A. Bismuth-212-labeled anti-Tac Mab: α-particle-emitting radionuclides as modalities for radioimmunotherapy. Proc. Natl. Acad. Sci. USA 83:474-478; 1986.
21. 211At, and external beam x-rays. Radiat. Res. 139:178-184; 1994.
22. 211At-methylene blue for pigmented melanoma in an animal model system. Cancer Res. 49:4332; 1989.
23. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: Treatment of cutaneous tumors and lymph node metastases. Cancer Res. 52:4385-4390; 1992.
24. Shipp, J. C.; Chaudhuri, B. N.; Matos, O. E.; Crevasse, L. E. Glucose and lipid metabolism in heart muscle: Effects of hypo- and hyperthyroidism. In: Tanz, R. D.; Kavaler, F.; Roberts, J., eds. Factors influencing myocardial contractility. New York: Academic Press; 1967:423-433.
25. Skipper, H. E.; Schmidt, L. H. A manual of quantitative drug evaluation in experimental tumor systems. Cancer Chemother. Rep. 17:1-143; 1962.
26. 211At] astatobenzylguanidine on human neuroblastoma cells. Cancer Res. 54:5414-5419; 1994.
27. 211At]astatobenzyl)guanidine: Synthesis via astato-demetalation and preliminary in vitro and in vivo evaluation. Bioconjugate Chem. 3:499-503; 1992.
28. Vedeneyev, V. I.; Gurvich, L. V.; Kondrat'yev, V. N.; Medvedev, V. A.; Frankevich, Y. L. Bond energies, ionization potentials and electron affinities. New York: St. Martin's Press; 1966.
29. 32P colloids in a murine intraperitoneal tumor mode. Gynecol. Oncol. 47:366-372; 1992.
30. 1) mice. J. Natl. Cancer Instit. 63:849-854; 1979.
31. 211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab′)2. Nucl. Med. Biol. 20:917-927; 1993.
32. Yokoro, K.; Kunii, A.; Furth, J.; Durbin, P. W. Tumor induction with astatine-211 in rats: Characterization of pituitary tumors. Cancer Res. 24:683-688; 1964.
33. Zalutsky, M. R.; Garg, P. K.; Friedman, H. S.; Bigner, D. D. Labeling monoclonal antibodies and F(ab)′2 fragments with the α-particle-emitting nuclide astatine-211: Preservation of immunoreactivity and in vivo localizing capacity. Proc. Natl. Acad. Sci. USA 86:7149-7153; 1989.
34. Zalutsky, M. R.; McLendon, R. E.; Garg, P. K.; Archer, G. E.; Schuster, J. M.; Bigner, D. D. Radioimmunotherapy of neoplastic meningitis in rats using an α-particle-emitting immunoconjugate. Cancer Res. 54:4719-4725; 1994.